Cargando…
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
MicroRNAs (miRNAs) are small non-coding nucleic acids able to post-transcriptionally regulate gene expression by binding to complementary sequences of target messenger RNA (mRNA). It has been estimated that at least 1% of the human genome encodes miRNA and every miRNA can regulate up to 200 mRNAs. T...
Autores principales: | Angelucci, Francesco, Cechova, Katerina, Valis, Martin, Kuca, Kamil, Zhang, Bing, Hort, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591466/ https://www.ncbi.nlm.nih.gov/pubmed/31275145 http://dx.doi.org/10.3389/fphar.2019.00665 |
Ejemplares similares
-
Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive Deficits
por: Hort, Jakub, et al.
Publicado: (2019) -
Antibiotics, gut microbiota, and Alzheimer’s disease
por: Angelucci, Francesco, et al.
Publicado: (2019) -
Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: Consequences on extracellular maturation of brain‐derived neurotrophic factor and therapeutic implications
por: Angelucci, Francesco, et al.
Publicado: (2018) -
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
por: Valis, Martin, et al.
Publicado: (2019) -
Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova, Blanka, et al.
Publicado: (2015)